secwatch.observer — SEC 8-K summary
======================================

Issuer:     EXELIXIS, INC. (EXEL)
CIK:        0000939767
Form:       8-K
Filed at:   2022-07-19T23:59:59+00:00
Accession:  0000939767-22-000083
Event type: litigation
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Exelixis sues MSN for generic CABOMETYX, asserting new patent expiring 2032
---------------------------------------------------------------------------

- Filed patent infringement suit against MSN for generic CABOMETYX, asserting U.S. Patent No. 11,298,349 (expires Feb 10, 2032).
- This is the fourth case; prior cases involve patents expiring Oct 8, 2030 and Jan 15, 2030, with trials in May 2022 (pending) and May 2023.
- Exelixis seeks injunction to block FDA approval of MSN's ANDA until expiration of the asserted patents.
- No trial date set for this new case; litigation ongoing in Delaware District Court.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/939767/000093976722000083/0000939767-22-000083-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/939767/000093976722000083/exel-20220718.htm
  HTML page:      https://secwatch.observer/filing/0000939767-22-000083

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer